| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 23/12/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment | NASDAQ:AMIX | Autonomix Medical Inc |
| 19/12/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/12/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 | NASDAQ:AMIX | Autonomix Medical Inc |
| 04/12/2024 | 00:17 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/11/2024 | 23:12 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/11/2024 | 22:00 | GlobeNewswire Inc. | Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/11/2024 | 12:30 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/11/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:AMIX | Autonomix Medical Inc |
| 22/11/2024 | 15:15 | GlobeNewswire Inc. | Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering | NASDAQ:AMIX | Autonomix Medical Inc |
| 12/11/2024 | 22:02 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] | NASDAQ:AMIX | Autonomix Medical Inc |
| 11/11/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/11/2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:AMIX | Autonomix Medical Inc |
| 01/11/2024 | 14:03 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under the Securities Act of 1933 | NASDAQ:AMIX | Autonomix Medical Inc |
| 31/10/2024 | 13:00 | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction | NASDAQ:AMIX | Autonomix Medical Inc |
| 30/10/2024 | 13:30 | GlobeNewswire Inc. | Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 28/10/2024 | 13:00 | GlobeNewswire Inc. | Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/10/2024 | 17:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th | NASDAQ:AMIX | Autonomix Medical Inc |
| 22/10/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Announces Reverse Stock Split | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/10/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC | NASDAQ:AMIX | Autonomix Medical Inc |
| 20/09/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum | NASDAQ:AMIX | Autonomix Medical Inc |
| 09/09/2024 | 13:00 | GlobeNewswire Inc. | Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/09/2024 | 00:27 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:AMIX | Autonomix Medical Inc |
| 27/08/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference | NASDAQ:AMIX | Autonomix Medical Inc |
| 23/08/2024 | 23:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:AMIX | Autonomix Medical Inc |
| 21/08/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress | NASDAQ:AMIX | Autonomix Medical Inc |
| 13/08/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones | NASDAQ:AMIX | Autonomix Medical Inc |
| 26/07/2024 | 23:14 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | NASDAQ:AMIX | Autonomix Medical Inc |
| 26/07/2024 | 22:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AMIX | Autonomix Medical Inc |
| 24/07/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology | NASDAQ:AMIX | Autonomix Medical Inc |
| 22/07/2024 | 15:05 | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series | NASDAQ:AMIX | Autonomix Medical Inc |